Controlled Release Excipient

THE STRATEGIC SHIFT IN ORAL DRUG DELIVERY THE STRATEGIC SHIFT IN ORAL DRUG DELIVERY Oral administration remains the gold standard...

Abstract Poloxamer-based hydrogels, composed of thermoreversible triblock copolymers, are promising drug delivery systems due to their ability to transition from...

Abstract Extended-release (ER) oral formulations provide therapeutic and practical benefits for pediatric patients by minimizing fluctuations in systemic exposure, reducing...

Abstract Background: Rebamipide (REB) is a poorly water-soluble drug with limited ocular bioavailability, necessitating advanced delivery strategies for sustained therapy in...

Abstract Purpose Cabazitaxel (CBZ) is a semi-synthetic anti-cancer drug and belongs to BCS class IV category with poor water solubility...

Abstract Background/Objectives: Rebamipide is a gastroprotective agent with poor aqueous solubility and rapid gastrointestinal clearance, leading to reduced therapeutic efficiency. This...

Abstract The rapid development of artificial intelligence (AI) and the increasing demand for the modernization of Chinese herbal medicine (CHM)...

Abstract Aqueous colloidal dispersions of water-insoluble polymers (APDs) —commonly referred to as pharmaceutical latexes or pseudolatexes— are extensively employed in...

CELLETS® Pharmaceutical Starter Cores for Pellets & Functional Coatings CELLETS® are high-purity pharmaceutical starter cores. They combine spherical geometry with...

Abstract SmartLipids represent the third generation of lipid-based nanocarriers, emerging as a transformative innovation in modern drug delivery and formulation...